The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients

Clinical trial NCT02297620 · COMPLETED

Trial details

NCT number: NCT02297620
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes

Start date: 2014-04-01
Primary completion: 2015-07-01
Enrollment: 8687

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.